|
|
|
| home > pmps > current issue |
|
|
 PUBLICATIONS |
Pharmaceutical Manufacturing and Packing Sourcer |
|
|
|
|
|
 |
| |
|
|
|
|
|
End of the Line
Why Automate?
PMPS Industry Advisor Randice Altschul looks into automation, why companies should employ these processes and the consequences if they don’t. She outlines why it is essential for pharmaceutical companies to turn to automation if they want to stay ahead.
|
|
|
|
|
Spotlight
The Long and the Short of Transdermal Drug Delivery
Stephan Brakel at 3M Drug Delivery Systems writes about the innovative products used at 3M, from microneedles to patches, and how to find the right partner in the pharmaceutical industry.
|
|
|
|
Spotlight
Accurate, Precise Microlitre Dosing
Congruence Medical Solutions discuss their microlitre syringes and how they can offer greater accuracy and precision, helping treat conditions such as age-related muscular degeneration and diabetic macular edema.
|
|
|
|
Spotlight
A Strong Partner from Drug Discovery to Delivery
Manufacturers are facing increasingly complex requirements when it comes to the development of new drug solutions, and, to help ease this issue during drug development, Datwyler has launched its Starter Pack solution with SCHOTT.
|
|
|
|
Viscosity, Needle Diameter, Flow Rate, and Dosage
Accuracy in Patch Pump Therapy
Michael Girschweiler at Sensile Medical evaluates the effectiveness and limitations of patch pump therapy.
|
|
|
|
Wearable Injection Devices
Considering Human Factors
Sorrel Medical’s Andrei Yosef highlights the trend of patients becoming more active in their healthcare treatments, and suggests that self-administering injection devices will enable patients to take greater control.
|
|
|
|
|
|
IT/OT Convergence
The End Game of the Automation Pyramid
With advances in technology and automation, the traditional structures may be about to collapse. Stefan Reuther at COPA-DATA writes about levels of automation in manufacturing processes.
|
|
|
|
The Industry 4.0 Journey
Planning Your Automation Project
Other industries are taking to automation and reaping the benefits, so why not the pharmaceutical industry? Jonathan Wilkins at EU Automation examines how a more robust, modern manufacturing approach can reduce disruptions and product failures, helping meet clinical performance.
|
|
|
|
Workflows for Artwork Management
Automated Processes
To ensure compliance, improve collaboration, and eliminate packaging delays, alternative methods need to be considered when it comes to labelling medical products, suggests Paul Goldberg at Loftware.
|
|
|
|
Integrating PAT and Robotics
A Match Made in Heaven
Integrating process analytical technologies and robotic process automation systems will produce a more efficient and streamlined manufacturing line and help your company reduce costs, claims Martin Gadsby at Optimal Group.
|
|
|
|
Exploring the Opportunities of Automation
The Future of Clinical Trial Design
Advancements made in technology are forcing changes in the way clinical trials are managed. Dave Wilson and John Morrison at Sharp Clinical Services examine the benefits of automation at every stage of the clinical supply chain.
|
|
|
|
|
Spotlight
Certified Solutions for Temperature Control
Swiss WorldCargo discusses how it ships its temperature-sensitive shipments worldwide using both active and passive solutions, which require innovative and fast-paced handling.
|
|
|
|
Passive Packaging: Challenges and Benefits
Redefining Supply
As our drugs modernise and develop, so does the way we transport and store them. Josie Morris at Woolcool explains how pharmaceutical companies have begun using passive packaging to deliver temperature controlled products in a simple, cost-effective, and reliable way.
|
|
|
|
Innovations in Cold Chain Technology
A Cold Case
Many drugs have to be stored at certain temperatures to remain in optimal condition. To achieve this, it is essential that trial sponsors consider a range of factors at every stage of the supply chain, says Brian Keesee at PCI Clinical Services.
|
|
|
|
|
Overlooked Factors in Clinical Labelling
Staying Ahead of the Curve
Labelling may seem like an minor part of drug manufacturing, but James McAleavey at Almac Clinical Services examines the importance of labelling in relation to clinical trials.
|
|
|
|
Spotlight
Connecting the Disconnected
If a single integrated cloud-based system existed for labelling pharmaceutical products, it could provide complete transparency and traceability across the entire industry. Graham Francis at Kallik suggests that, despite the data challenge, we should all aim towards implementing cloud-based systems.
|
|
|
|
Spotlight
Taking the Lead
PSCI discuss how they champion responsible practices in the pharmaceutical supply chain, whether it be environmentally, or in the form of labour rights, worker welfare, safety and hygiene, or good governance.
|
|
|
|
Supply Chain and Logistics
A Seamless Supply
As clinical trials are becoming larger and more complex, the different stages of these trials face new and diverse challenges, and the supply chain must be controlled, says Celine Chanforan at Onorach.
|
|
|
|
The Impact of Poor Adherence
The Promise of Connected Health
Up to 50% of patients do not take their medication as prescribed. Medication nonadherence costs the pharmaceutical industry approximately $188 billion in lost revenue. Kevin Deane at Phillips-Medisize writes on how to support patient adherence to prescribed medicine.
|
|
|
|
Securing Supply with Blockchain Technology
Blocking Counterfeits
Serialisation of drugs in the supply chain is essential to blocking counterfeits, and many companies are adopting track and trace to increase security. Although blockchain is still in its infancy, Tom Egan at PMMI, Rick Fox at Fox VI Technologies, and Bill McBeath at ChainLink Research explore its advantages.
|
|
|
|
|
Global Label Management
Why so Persistently Unruly?
With the global labelling management burden in life sciences soaring, and companies expanding into new markets, it is essential that pharmaceutical companies produce accurate compliant labelling in all of their markets. Agnes Cwienczek at AMPLEXOR discusses the intensity of labelling in the pharma industry.
|
|
|
|
NFC Smart Packaging
Serialising Drugs to Combat Fraud
Drug fraud accounts for only 2% of sales, but the rate that this has grown is a cause for concern, especially with the rise of online sales. Gillian Ewers at PragmatIC explores the value of serialisation.
|
|
|
|
Increasing Medication Safety
All About the Box
Ineffective packaging can lead to mix-ups and incorrect dispensing. To make medication safer, Oliver Pittock at Valley Northern writes that pharmaceutical manufacturers must address current pharma packaging so pharmacists don’t get confused between their Daptomycins and Dactinomycins.
|
|
|
|
|
Greater Copenhagen
The Growing Hotspot for Global Logistics
This October, the FlyPharma Conference Europe will be held in Denmark, moving to the Nordics for the first time. Paul Dhami at Copenhagen Capacity discusses the benefits of hosting the conference in the Greater Copenhagen area.
|
|
|
|
Event Preview
At the Forefront of Pharmaceutical Logistics
The FlyPharma Conference Europe will be held in Copenhagen on 22-23 October, centring on pharmaceutical cargo industry trends and future challenges in pharma logistics.
|
|
|
|
Scandinavian Manufacturing and R&D
Scandinavian Sciences
Given that the pharmaceutical sector is one of the major industries in Scandinavia, Zdeněk Pečený explores the economic successes and the reasons that allow Medicon Valley to flourish.
|
|
|
|
Nordic Life Sciences
Leaving on a Jet Plane
Petter Hartman at Medicon Valley Alliance breaks down the framework of life sciences in Scandinavia and explains how pharmaceutical companies can benefit from operating in the Medicon Valley region.
|
|
|
|
|
|
 |
|
|
 |
News and Press Releases |
 |
Vaisala Introduces CAB100 Industrial Cabinet for Cleanrooms
Vaisala, a global leader in weather, environmental, and industrial measurements, launches its newest offering for centralized environmental monitoring in cleanrooms: The CAB100 integrates Vaisala’s world-class instruments for monitoring parameters into a simple, pre-configured enclosure.
More info >> |
|
 |
White Papers |
 |
|
Biosimilars In Emerging Markets: Is It A Level Playing Field?
PRA Health Sciences (PRA)
Governments, healthcare payers, and social and health reforms, combined with the increased incidence of conditions such as cancer and diabetes are paving the way for increased uptake of biologic medicines in emerging markets. However, expensive biologic medicines can be prohibitive to many patients, creating a high level of unmet clinical need. At its best, the global expansion of biosimilars can mean a robust and steady supply of existing and new drugs reaching far-flung patient populations, but localized biosimilar drug developments, especially in China and India, combined with a lack of robust pharmacovigilance systems, threaten to derail the industry by putting patient health at risk.
More info >> |
|
 |
Industry Events |
 |
FlyPharma Europe
22-23 October 2019, Copenhagen, Denmark
The FlyPharma Conference Europe 2019 is aimed at forward-thinking individuals and
businesses that are ready to uncover the potential in their pharma supply chain. The
event offers an interactive platform to discuss current and future challenges within
pharma and cargo, with topics including market trends, cold chain innovations, latest
regulatory demands, security technology, and how to encourage collaboration between
supply chain players.
There will be plenty of networking opportunities, including a complimentary evening
networking event, where delegates can meet and catch up with senior and executive
pharma
and cargo professionals – gaining strong, new industry contacts and building on
existing ones.
More info >> |
|
|
